secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0001104659-23-103032
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PTC Therapeutics removes redactions from $300M credit agreement, disclosing Events of Default terms
--------------------------------------------------------------------------------

- Filed unredacted Credit Agreement dated Oct 27, 2022; initial term loan facility of $300M and delayed draw up to $150M.
- Company no longer seeks confidential treatment for Section 8.01 (Events of Default) and other provisions.
- Credit agreement also contemplates up to $500M in incremental investments subject to lender consent.
- Lenders include Blackstone-related entities; interest rate is Adjusted Term SOFR + 7.25%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000110465923103032/0001104659-23-103032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000110465923103032/tm2326714d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-103032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer